Back to News
Market Impact: 0.2
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
Source: zacks.com
Product LaunchesHealthcare & BiotechCompany Fundamentals
Fresenius Medical Care launched its multiFiltratePRO kidney therapy system in the United States, adding a critical-care treatment option. The company described the launch as an expansion of growth opportunities; no financial figures or market reaction were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
FMS0.55
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- Kinder Morgan, Energy Transfer and Williams could benefit from cheap natural gas